Resource Logo
PR Newswire

Flu Season is Approaching: Safe in Common Urges Flu Vaccine Providers To Demand Syringes with Needlestick Prevention Features




 

NEW YORK, Aug. 15, 2012 /PRNewswire/ -- This fall and winter, approximately 150 million doses of flu vaccine will be administered across the U.S during the influenza season - which means one injection will be given to almost one in every two U.S. citizens.  Safe in Common, a non-profit organization established to promote needlestick safety and build a community of healthcare safety advocates, today issued a reminder to healthcare facilities and other public sites that will administer the flu vaccine to use syringes with safety features that can protect providers from the risk needlestick injuries.

The Center for Disease Control recommends everyone who is at least six months of age get a flu vaccine before the flu season, which the CDC tracks from October 2012 to May 2013. Administration of the flu vaccine will occur in both controlled environments, such as hospitals and physician's offices, as well as shopping malls, drug stores and other public areas.

The majority of flu vaccine doses will be administered to patients in either a prefilled or hypodermic syringe. To comply with federal Bloodborne Pathogens Standard, employers are required to use syringes with safety-engineered equipment, where commercially available, to help protect healthcare personnel and others at potential risk of infection from HIV, Hepatitis C and other modes via needlestick injuries. Employers who fail to comply with the requirements of the Bloodborne Pathogens Standard risk being issued with citations and financial penalties by the U.S. Occupational Safety and Health Administration.  

According to Dr. Mary Foley, Chairperson of Safe in Common, healthcare personnel and other employees engaged in the administration of a flu vaccine are amongst those at greatest risk of needlestick injury.

"The hectic environments where flu vaccines are often given, as well as safety deficiencies in the syringes typically used for these injections, can put healthcare personnel at significant risk of incurring a needlestick injury. Safe in Common is calling for all providers of the flu vaccine to stock sufficient supplies of safety-engineered equipment and appropriate disposal systems to cover every flu vaccine that will be given at their site," Dr. Foley said.

Because flu vaccines are typically administered by intramuscular injection, it is routine procedure for syringes to be supplied without needles so that healthcare personnel can select a needle of appropriate length to accommodate the needs of each target patient. Dr. Foley said the safety needles that are commonly used for intramuscular injections provided healthcare personnel with sub-optimal levels of protection.

"The goal for every injection where there is risk of a needlestick injury should be the removal of harm as quickly as possible. All too often, flu vaccinations are given with syringes that are attached with standard luer needles. This is no longer acceptable practice within U.S. healthcare facilities, and we encourage people to speak up when they see syringes without safety features being used.

"But even where a safety product such as a needle guard is utilized, an operator must first remove the used syringe from the body of the patient before manually engaging the needlestick prevention mechanism. Needlestick injuries often occur either before or during the activation of these manual safety products, or because the operator elects not to engage the safety mechanism at all. We encourage pharmaceutical manufacturers to provide their flu vaccines prefilled with products with integrated and automatic safety features that can deliver optimal levels of protection to healthcare personnel.  We also want to let healthcare personnel know that if these devices are not available currently, they have the right to demand them.  It is their health that is at risk," Dr. Foley concluded.

The U.S. Occupational Safety and Health Administration estimates 5.6 million workers in the U.S. healthcare industry are at risk of occupational exposure to bloodborne pathogens via needlestick injuries and other sharps-related injuries and the Centers for Disease Control and prevention reports that 385,000 needlestick injuries and other sharps-related injuries are sustained annually by hospital-based healthcare personnel.

Safe in Common works to eradicate needlestick and sharps related injuries and to promote the adoption of safer engineering controls in healthcare settings through education and training. Backed by a community of thousands of healthcare personnel, SIC is raising awareness of Needlestick injury prevention and gathering signatures for the Organization's Needlestick Safety Pledge as a step toward prevention.

For more information about Safe in Common or to learn about partnership opportunities and the Organization's ongoing work to promote utilizing safer engineering controls that protect healthcare workers from unnecessary needlestick and sharps related injuries, please visit http://www.safeincommon.org.

About Safe in Common

Safe in Common is a non-profit organization established to enhance and save the lives of U.S. healthcare personnel at risk of harm from needlesticks and sharps injuries.  It is led by Chairperson Mary Foley, PhD, RN, former President of the American Nurses Association and other industry leaders. To learn more about the Needlestick Safety Pledge and its goal of promoting and strengthening the Federal Needlestick Safety and Prevention Act, go to www.facebook.com/safeincommon and follow Safe in Common on Twitter at www.twitter.com/safeincommon.

Media Contacts:

Joe McGurk / Caitlin Cox
KCSA Strategic Communications
jmcgurk@kcsa.com / ccox@kcsa.com
P: 212-896-1231 / 212-896-1289

SOURCE  Safe in Common

Web Site: http://www.safeincommon.org



 


Copyright © 2012 -PR Newswire, Publisher. All rights reserved to PR Newswire.. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PR Newswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019.

Information in this article was accurate in August 15, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.